FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Roy First

Research Profile

Procedures

Physiology

Chemicals & Drugs

Concepts & Ideas

Living Beings

Co-author Network

Publications

TOP 3
Michael J Hanaway; E Steve Woodle; Shamkant Mulgaonkar; V Ram Peddi; Dixon B Kaufman; M Roy First; Richard Croy; John Holman
Alemtuzumab induction in renal transplantation.
Antonio Guasch; Prabir Roy-Chaudhury; E Steve Woodle; William E Fitzsimmons; John Holman; M Roy First
Assessment of efficacy and safety of FK778 in comparison with standard care in renal transplant recipients with untreated BK nephropathy.
Yun Miao; Jason J Everly; Thomas G Gross; Amit D Tevar; M Roy First; Rita R Alloway; E Steve Woodle
De novo cancers arising in organ transplant recipients are associated with adverse outcomes compared with the general population.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Roy First (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Michael J Hanaway; E Steve Woodle; Shamkant Mulgaonkar; V Ram Peddi; Dixon B Kaufman; M Roy First; Richard Croy; John Holman
Alemtuzumab induction in renal transplantation.
The New England journal of medicine 2011;364(20):1909-19.
2010: Antonio Guasch; Prabir Roy-Chaudhury; E Steve Woodle; William E Fitzsimmons; John Holman; M Roy First
Assessment of efficacy and safety of FK778 in comparison with standard care in renal transplant recipients with untreated BK nephropathy.
Transplantation 2010;90(8):891-7.
2009: Yun Miao; Jason J Everly; Thomas G Gross; Amit D Tevar; M Roy First; Rita R Alloway; E Steve Woodle
De novo cancers arising in organ transplant recipients are associated with adverse outcomes compared with the general population.
Transplantation 2009;87(9):1347-59.
2009: Jennifer K Walker; Rita R Alloway; Prabir Roy-Chaudhury; Gautham Mogilishetty; Michael Cardi; Nicole A Weimert; Adele H Rike; M Roy First; E Steve Woodle
A prospective trial of a steroid-free/calcineurin inhibitor minimization regimen in human leukocyte antigen (HLA)-identical live donor renal transplantation.
Transplantation 2009;87(3):408-14.
2008: E Steve Woodle; M Roy First; John Pirsch; Fuad Shihab; A Osama Gaber; Paul Van Veldhuisen
A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy.
Annals of surgery 2008;248(4):564-77.
2008: Paul Bolin; Fuad S Shihab; Laura L Mulloy; Alice K Henning; Jeff Gao; Marilyn Bartucci; John Holman; M Roy First
Optimizing tacrolimus therapy in the maintenance of renal allografts: 12-month results.
Transplantation 2008;86(1):88-95.
2008: Fuad S Shihab; Thomas H Waid; David J Conti; Harold Yang; Michael J Holman; Laura L Mulloy; Alice K Henning; John Holman; M Roy First
Conversion from cyclosporine to tacrolimus in patients at risk for chronic renal allograft failure: 60-month results of the CRAF Study.
Transplantation 2008;85(9):1261-9.
2008: M Roy First
First clinical experience with the new once-daily formulation of tacrolimus.
Therapeutic drug monitoring 2008;30(2):159-66.
2007: Rita R Alloway; Steven Steinberg; Kassem Khalil; Sita Gourishankar; Joshua Miller; Douglas J Norman; Sundaram Hariharan; John D Pirsch; Arthur J Matas; Jeffrey S Zaltzman; Kathleen Wisemandle; William E Fitzsimmons; M Roy First
Two years postconversion from a prograf-based regimen to a once-daily tacrolimus extended-release formulation in stable kidney transplant recipients.
Transplantation 2007;83(12):1648-51.
2007: Sander Florman; Rita R Alloway; Munci Kalayoglu; Jeffrey D Punch; Thomas Bak; J Keith Melancon; Goran B Klintmalm; Stephan Busque; Michael Charlton; John Lake; Shobha Dhadda; Kathleen Wisemandle; Mary Wirth; William E Fitzsimmons; John Holman; M Roy First
Once-daily tacrolimus extended release formulation: experience at 2 years postconversion from a Prograf-based regimen in stable liver transplant recipients.
Transplantation 2007;83(12):1639-42.
2007: Thomas G Heffron; M D Pescovitz; Sander Florman; Munci Kalayoglu; S Emre; Gregory A Smallwood; Kathleen Wisemandle; C Anania; Shobha Dhadda; Taiji Sawamoto; James Keirns; William E Fitzsimmons; M Roy First
Once-daily tacrolimus extended-release formulation: 1-year post-conversion in stable pediatric liver transplant recipients.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2007;7(6):1609-15.
2007: H T Silva; H C Yang; Marwan Abouljoud; Paul C Kuo; Kathleen Wisemandle; P Bhattacharya; Shobha Dhadda; J Holman; William E Fitzsimmons; M Roy First
One-year results with extended-release tacrolimus/MMF, tacrolimus/MMF and cyclosporine/MMF in de novo kidney transplant recipients.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2007;7(3):595-608.
2007: E Steve Woodle; Rita R Alloway; Adele Rike; Prabir Roy-Chaudhury; Amit Tevar; Brian Susskind; Jason Everly; Gautham Mogilishetty; Paul Brailey; Amit Govil; Steven M Rudich; M Roy First; J Wesley Alexander; Rino Munda; Michael Cardi; Lois J Arend
Corticosteroid elimination: the Cincinnati experience.
Clinical transplants 2007;():51-60.
2006: Alesha Luxon; M Roy First
Diabetes: one part of the cardiovascular problem post-transplant.
Nephrology news & issues 2006;20(10):33-4.
2005: E Steve Woodle; Rita R Alloway; Joseph F Buell; J Wesley Alexander; Rino Munda; Prabir Roy-Chaudhury; M Roy First; Michael Cardi; Jennifer Trofe
Multivariate analysis of risk factors for acute rejection in early corticosteroid cessation regimens under modern immunosuppression.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005;5(11):2740-4.
2005: Christin C Rogers; Rita R Alloway; Joseph F Buell; Robyn Boardman; J Wesley Alexander; Michael Cardi; Prabir Roy-Chaudhury; M Roy First; Paul A Succop; Rino Munda; E Steve Woodle
Body weight alterations under early corticosteroid withdrawal and chronic corticosteroid therapy with modern immunosuppression.
Transplantation 2005;80(1):26-33.
2005: Jennifer Trofe; Joseph F Buell; Thomas M Beebe; Michael J Hanaway; M Roy First; Rita R Alloway; Thomas G Gross; P Succop; E Steve Woodle
Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients: the Israel Penn International Transplant Tumor Registry experience.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005;5(4 Pt 1):775-80.
2005: Joseph F Buell; Thomas M Beebe; Thomas G Gross; Jennifer Trofe; Michael J Hanaway; Rita R Alloway; M Roy First; E Steve Woodle
United network for organ sharing publication on scientific registry of transplant recipients central nervous system donor cancer transmission data.
Transplantation 2005;79(5):623.
2005: Sander Florman; Rita R Alloway; Munci Kalayoglu; K Lake; Thomas Bak; A Klein; Goran B Klintmalm; Stephan Busque; D Brandenhagen; John Lake; Kathleen Wisemandle; William E Fitzsimmons; M Roy First
Conversion of stable liver transplant recipients from a twice-daily Prograf-based regimen to a once-daily modified release tacrolimus-based regimen.
Transplantation proceedings 2005;37(2):1211-3.
2005: E Steve Woodle; Manish Gupta; Joseph F Buell; Guy W Neff; Thomas G Gross; M Roy First; Michael J Hanaway; Jennifer Trofe
Prostate cancer prior to solid organ transplantation: the Israel Penn International Transplant Tumor Registry experience.
Transplantation proceedings 2005;37(2):958-9.
2005: Joseph F Buell; Thomas G Gross; Michael J Hanaway; Jennifer Trofe; C Muthiak; M Roy First; Rita R Alloway; E Steve Woodle
Chemotherapy for posttransplant lymphoproliferative disorder: the Israel Penn International Transplant Tumor Registry experience.
Transplantation proceedings 2005;37(2):956-7.
2005: Joseph F Buell; Thomas G Gross; Michael J Hanaway; Jennifer Trofe; Prabir Roy-Chaudhury; M Roy First; E Steve Woodle
Posttransplant lymphoproliferative disorder: significance of central nervous system involvement.
Transplantation proceedings 2005;37(2):954-5.
2005: Rita R Alloway; S Steinberg; K Khalil; Sita Gourishankar; J Miller; Douglas J Norman; S Hariharan; John D Pirsch; Arthur J Matas; Jeffrey S Zaltzman; Kathleen Wisemandle; William E Fitzsimmons; M Roy First
Conversion of stable kidney transplant recipients from a twice daily Prograf-based regimen to a once daily modified release tacrolimus-based regimen.
Transplantation proceedings 2005;37(2):867-70.
2005: Robyn Boardman; Rita R Alloway; J Wesley Alexander; Joseph F Buell; Michael Cardi; M Roy First; M T Hanaway; Rino Munda; Christin C Rogers; Prabir Roy-Chaudhury; Brian Susskind; Jennifer Trofe; E Steve Woodle
African American renal transplant recipients benefit from early corticosteroid withdrawal under modern immunosuppression.
Transplantation proceedings 2005;37(2):814-6.
2005: Joseph F Buell; Michael J Hanaway; Mark Thomas; Rino Munda; Rita R Alloway; M Roy First; E Steve Woodle
Donor kidneys with small renal cell cancers: can they be transplanted?
Transplantation proceedings 2005;37(2):581-2.
2005: J Wesley Alexander; Timothy J Metze; Matthew J McIntosh; Hope R Goodman; M Roy First; Rino Munda; Michael Cardi; Joe N Austin; Sharad Goel; Shahzad Safdar; Norman Greenberg; Xiaowu Chen; E Steve Woodle
The influence of immunomodulatory diets on transplant success and complications.
Transplantation 2005;79(4):460-5.
2005: Joseph F Buell; Lucy Lee; Jill E Martin; Natalie A Dake; Teresa M Cavanaugh; Michael J Hanaway; Pat Weiskittel; Rino Munda; J Wesley Alexander; Michael Cardi; V Ram Peddi; Edward Y Zavala; Elaine Berilla; Marketa Clippard; M Roy First; E Steve Woodle
Laparoscopic donor nephrectomy vs. open live donor nephrectomy: a quality of life and functional study.
Clinical transplantation 2005;19(1):102-9.
2005: Robyn Boardman; Rita R Alloway; J Wesley Alexander; Joseph F Buell; Michael Cardi; M Roy First; Michael J Hanaway; Rino Munda; Christin C Rogers; Prabir Roy-Chaudhury; Brian Susskind; Jennifer Trofe; E Steve Woodle
African-American renal transplant recipients benefit from early corticosteroid withdrawal under modern immunosuppression.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005;5(2):356-65.
2004: William E Fitzsimmons; M Roy First
FK778, a synthetic malononitrilamide.
Yonsei medical journal 2004;45(6):1132-5.
2004: M Roy First; William E Fitzsimmons
Modified release tacrolimus.
Yonsei medical journal 2004;45(6):1127-31.
2004: Meredith J Aull; Joseph F Buell; Jennifer Trofe; M Roy First; Rita R Alloway; Michael J Hanaway; Lynne E Wagoner; Thomas G Gross; Thomas M Beebe; E Steve Woodle
Experience with 274 cardiac transplant recipients with posttransplant lymphoproliferative disorder: a report from the Israel Penn International Transplant Tumor Registry.
Transplantation 2004;78(11):1676-82.
2004: M Roy First
Improving long-term renal transplant outcomes with tacrolimus: speculation vs evidence.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004;19 Suppl 6():vi17-vi22.
2004: M Roy First
Tacrolimus based immunosuppression.
Journal of nephrology 2004;17 Suppl 8():S25-31.
2004: Jennifer Trofe; Joseph F Buell; E Steve Woodle; Thomas M Beebe; Michael J Hanaway; M Roy First; Rita R Alloway; Thomas G Gross
Recurrence risk after organ transplantation in patients with a history of Hodgkin disease or non-Hodgkin lymphoma.
Transplantation 2004;78(7):972-7.
2004: Jennifer Trofe; Thomas M Beebe; Joseph F Buell; Michael J Hanaway; M Roy First; Rita R Alloway; Thomas G Gross; E Steve Woodle
Posttransplant malignancy.
Progress in transplantation (Aliso Viejo, Calif.) 2004;14(3):193-200.
2004: Thomas G Peters; Kristin N Spinola; John C West; Mark I Aeder; Gabriel M Danovitch; Goran B G Klintmalm; Kevin J Gorman; John A Gordon; Carl H Kincaid; M Roy First
Differences in patient and transplant professional perceptions of immunosuppression-induced cosmetic side effects.
Transplantation 2004;78(4):537-43.
2004: M Roy First; William E Fitzsimmons
New drugs to improve transplant outcomes.
Transplantation 2004;77(9 Suppl):S88-92.
2004: M Roy First
New-onset diabetes after transplantation.
Transplantation 2004;77(7):1128-9;author reply 1129-30.
2003: Joseph F Buell; Jennifer Trofe; Gopalan Sethuraman; Michael J Hanaway; Thomas M Beebe; Thomas G Gross; Rita R Alloway; M Roy First; E Steve Woodle
Donors with central nervous system malignancies: are they truly safe?
Transplantation 2003;76(2):340-3.
2003: M Roy First
Posttransplant diabetes mellitus.
Transplantation 2003;75(10):1769.
2003: M Roy First
Renal function as a predictor of long-term graft survival in renal transplant patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2003;18 Suppl 1():i3-6.
2003: Meredith J Aull; Joseph F Buell; V Ram Peddi; Jennifer Trofe; Thomas M Beebe; Michael J Hanaway; Prabir Roy-Chaudhury; Rita R Alloway; M Roy First; E Steve Woodle
MALToma: a Helicobacter pylori-associated malignancy in transplant patients: a report from the Israel Penn International Transplant Tumor Registry with a review of published literature.
Transplantation 2003;75(2):225-8.
2003: Beth Ann Witherow; Gregory S Roth; Mark A Carrozza; Ronald W Freyberg; Jonathan E Kopke; Rita R Alloway; Joseph F Buell; M Roy First; Thomas G Gross; Michael J Hanaway; Jennifer Trofe; E Steve Woodle; Thomas M Beebe
The Israel Penn International Transplant Tumor Registry.
AMIA ... Annual Symposium proceedings / AMIA Symposium. AMIA Symposium 2003;():1053.
2002: Joseph F Buell; Thomas L Husted; Michael J Hanaway; V Ram Peddi; Jennifer Trofe; Thomas G Gross; Thomas M Beebe; M Roy First; E Steve Woodle
Incidental diagnosis of gastric cancer in transplant recipients improves patient survival.
Surgery 2002;132(4):754-8; discussion 758-60.
2002: J Wesley Alexander; L L Stanley; T L Ofstedal; M Roy First; Michael Cardi; Shahzad Safdar; N C Mendoza; Rino Munda; James P Fidler; Joseph F Buell; Michael J Hanaway; E Steve Woodle
Transplantation without steroids.
Transplantation proceedings 2002;34(6):2076-8.
2002: Jennifer Trofe; T Cavallo; M Roy First; Pat Weiskittel; V Ram Peddi; Prabir Roy-Chaudhury; Rita R Alloway; Shahzad Safdar; Joseph F Buell; Michael J Hanaway; E Steve Woodle
Polyomavirus in kidney and kidney-pancreas transplantation: a defined protocol for immunosuppression reduction and histologic monitoring.
Transplantation proceedings 2002;34(5):1788-9.
2002: Thomas L Husted; Joseph F Buell; Michael J Hanaway; Jennifer Trofe; Thomas M Beebe; T Gross; M Roy First; E Steve Woodle
De novo sarcomas in solid organ transplant recipients.
Transplantation proceedings 2002;34(5):1786-7.
2002: Joseph F Buell; Thomas L Husted; Michael J Hanaway; Jennifer Trofe; T Gross; Thomas M Beebe; M Roy First; E Steve Woodle
Gastric cancer in transplant recipients: detection of malignancy [correction of malignacy] by aggressive endoscopy.
Transplantation proceedings 2002;34(5):1784-5.
2002: Joseph F Buell; Jennifer Trofe; Michael J Hanaway; Thomas M Beebe; Thomas G Gross; Rita R Alloway; M Roy First; E Steve Woodle
Immunosuppression and Merkel cell cancer.
Transplantation proceedings 2002;34(5):1780-1.
2002: Joseph F Buell; Michael J Hanaway; Jennifer Trofe; Thomas G Gross; Thomas M Beebe; Rita R Alloway; M Roy First; E Steve Woodle
De novo breast cancer in renal transplant recipients.
Transplantation proceedings 2002;34(5):1778-9.
2002: M Roy First
Immunosuppressive [correction of immunosupressive] agents and their actions.
Transplantation proceedings 2002;34(5):1369-71.
2002: V Ram Peddi; Margaret Bryant; Prabir Roy-Chaudhury; E Steve Woodle; M Roy First
Safety, efficacy, and cost analysis of thymoglobulin induction therapy with intermittent dosing based on CD3+ lymphocyte counts in kidney and kidney-pancreas transplant recipients.
Transplantation 2002;73(9):1514-8.
2002: M Roy First; David A Gerber; Sundaram Hariharan; Dixon B Kaufman; Ron Shapiro
Posttransplant diabetes mellitus in kidney allograft recipients: incidence, risk factors, and management.
Transplantation 2002;73(3):379-86.
2002: Jennifer Trofe; Joseph F Buell; M Roy First; Michael J Hanaway; Thomas M Beebe; E Steve Woodle
The role of immunosuppression in lymphoma.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2002;159():55-66.
2001: M Roy First; V Ram Peddi; Pat Weiskittel; E Steve Woodle
Control of risk factors for cardiovascular disease in long-term renal transplant recipients.
Transplantation proceedings 2001;33(7-8):3674-5.
2001: E Steve Woodle; Michael J Hanaway; Joseph F Buell; T Gross; M Roy First; Jennifer Trofe; Thomas M Beebe
Kaposi sarcoma: an analysis of the US and international experiences from the Israel Penn International Transplant Tumor Registry.
Transplantation proceedings 2001;33(7-8):3660-1.
2001: E Steve Woodle; Joseph F Buell; Michael J Hanaway; M Roy First; Jennifer Trofe
Biologic behavior of carcinoid tumors in solid organ transplant recipients: the Israel Penn international transplant tumor registry experience.
Transplantation proceedings 2001;33(7-8):3656-7.
2001: V Ram Peddi; Pat Weiskittel; J Wesley Alexander; E Steve Woodle; M Roy First
HLA-identical renal transplant recipients: immunosuppression, long-term complications, and survival.
Transplantation proceedings 2001;33(7-8):3411-3.
2001: Joseph F Buell; Jennifer Trofe; Michael J Hanaway; A Lo; Bruce R Rosengard; Horacio L R Rilo; Rita R Alloway; Thomas M Beebe; M Roy First; E Steve Woodle
Transmission of donor cancer into cardiothoracic transplant recipients.
Surgery 2001;130(4):660-6; discussion 666-8.
2001: M Roy First
Strategies to minimize immunological and nonimmunological risk factors in the renal transplant population.
Transplantation 2001;72(6 Suppl):S20-4.
2001: Burnett S Kelly; J Wesley Alexander; D Dreyer; NA Greenberg; A Erickson; James F Whiting; Cora K Ogle; George Babcock; M Roy First
Oral arginine improves blood pressure in renal transplant and hemodialysis patients.
JPEN. Journal of parenteral and enteral nutrition 2001;25(4):194-202.
2001: M Roy First
Case 2: Post-transplant diabetes mellitus in renal transplantation.
Transplantation 2001;71(12):1872-3.
2001: M Roy First
Case 1: persistent acute rejection after kidney transplantation.
Transplantation 2001;71(11):1697-8.
2001: V Ram Peddi; M Roy First
Recent advances in immunosuppressive therapy for renal transplantation.
Seminars in dialysis 2001;14(3):218-22.
2001: M Roy First
Tailoring immunosuppressive therapy based on donor and recipient risk factors.
Transplantation proceedings 2001;33(3):2207-11.
2001: A L Phillips; E L Walker; Jill E Martin; M Roy First; Douglas W Hanto; James F Whiting
Quality of life as a predictor of morbidity, mortality, and resource utilization after solid organ transplant.
Transplantation proceedings 2001;33(1-2):1922.
2001: Jill E Martin; Theresa I Shireman; M Roy First; James F Whiting
Quality of life following solid organ transplantation in Medicaid beneficiaries.
Transplantation proceedings 2001;33(1-2):1909.
2001: S R Boyd; Jill E Martin; M Roy First; James F Whiting
Health utility scores following renal transplantation.
Transplantation proceedings 2001;33(1-2):1900.
2001: A L Phillips; E L Walker; Jill E Martin; M Roy First; Douglas W Hanto; James F Whiting
Quality of life as a predictor of morbidity, mortality, and resource utilization after solid-organ transplant.
Transplantation proceedings 2001;33(1-2):1886.
2001: M Roy First
The organ shortage and allocation issues.
Transplantation proceedings 2001;33(1-2):806-10.
2001: P R Chaudhury; J Wesley Alexander; M Roy First; V Ram Peddi; Rino Munda; T Cavallo
Immediate allograft dysfunction due to atheroembolic disease.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2001;37(2):423-6.
2000: M R Brown; Amy Noffsinger; M Roy First; I Penn; Nader Husseinzadeh
HPV subtype analysis in lower genital tract neoplasms of female renal transplant recipients.
Gynecologic oncology 2000;79(2):220-4.
2000: James F Whiting; Robert S Woodward; Edward Y Zavala; DS Cohen; Jill E Martin; Gary G Singer; Jeffrey A Lowell; M Roy First; Daniel C Brennan; Mark A Schnitzler
Economic cost of expanded criteria donors in cadaveric renal transplantation: analysis of Medicare payments.
Transplantation 2000;70(5):755-60.
2000: M Roy First
Hepatitis C virus infection in the renal transplant recipient.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2000;15 Suppl 8():60-4.
1999: I Penn; M Roy First
Merkel's cell carcinoma in organ recipients: report of 41 cases.
Transplantation 1999;68(11):1717-21.
1999: J Wesley Alexander; J A Light; L A Donaldson; F L Delmonico; A G Diethelm; A Wilkinson; J Thomas Rosenthal; J R Thistlethwaite; Lawrence Hunsicker; Arthur J Matas; M Roy First; Nancy L Reinsmoen; S M Rose
Evaluation of pre- and posttransplant donor-specific transfusion/cyclosporine A in non-HLA identical living donor kidney transplant recipients. Cooperative Clinical Trials in Transplantation Research Group.
Transplantation 1999;68(8):1117-24.
1999: D E Dean; S Kamath; V Ram Peddi; TJ Schroeder; M Roy First; T Cavallo
A blinded retrospective analysis of renal allograft pathology using the Banff schema: implications for clinical management.
Transplantation 1999;68(5):642-5.
1999: DM Canafax; WD Irish; HB Moran; E Squiers; R Levy; P Pouletty; M Roy First; U Christians
An individual bioequivalence approach to compare the intrasubject variability of two ciclosporin formulations, SangCya and Neoral.
Pharmacology 1999;59(2):78-88.
1999: MB Shah; Jill E Martin; TJ Schroeder; M Roy First
The evaluation of the safety and tolerability of two formulations of cyclosporine: neoral and sandimmune. A meta-analysis.
Transplantation 1999;67(11):1411-7.
1999: TJ Schroeder; Linda Moore; Lillian W Gaber; A Osama Gaber; M Roy First
The US multicenter double-blind, randomized, phase III trial of thymoglobulin versus atgam in the treatment of acute graft rejection episodes following renal transplantation: rationale for study design.
Transplantation proceedings 1999;31(3B Suppl):1S-6S.
1999: J E Martin; AJ Daoud; TJ Schroeder; M Roy First
The clinical and economic potential of cyclosporin drug interactions.
PharmacoEconomics 1999;15(4):317-37.
1999: James F Whiting; Edward Y Zavala; J Wesley Alexander; M Roy First
The cost-effectiveness of transplantation with expanded donor kidneys.
Transplantation proceedings 1999;31(1-2):1320-1.
1999: V Ram Peddi; TJ Schroeder; Pat Weiskittel; M Roy First
Graft outcome in patients with biopsy-proven chronic renal allograft rejection.
Transplantation proceedings 1999;31(1-2):1308-9.
1999: V Ram Peddi; Rino Munda; AM Demmy; M Roy First
Long-term outcome in simultaneous kidney and pancreas transplant recipients with functioning allografts at 1-year posttransplantation.
Transplantation proceedings 1999;31(1-2):608-9.
1999: Robert S Gaston; R R Alloway; A O Gaber; S J Rossi; TJ Schroeder; WD Irish; DM Canafax; M Roy First
Pharmacokinetic and safety evaluation of SangCya vs Neoral or Sandimmune in stable renal transplant recipients.
Transplantation proceedings 1999;31(1-2):326-7.
1999: M Roy First; Pat Weiskittel; M L Burton; MB Shah; D Dreyer; PR Fleck; C Bey; V Ram Peddi; DM Canafax; TJ Schroeder
Nine-month follow-up of SangCya (Sang-35) in kidney transplant patients after conversion from Sandimmune.
Transplantation proceedings 1999;31(1-2):324-5.
1999: U M Khosla; Jill E Martin; G M Baker; TJ Schroeder; M Roy First
One-year, single-center cost analysis of mycophenolate mofetil versus azathioprine following cadaveric renal transplantation.
Transplantation proceedings 1999;31(1-2):274-5.
1999: MS Golconda; John F Valente; Pablo A Bejarano; Norman H Gilinsky; M Roy First
Mycophenolate mofetil-induced colonic ulceration in renal transplant recipients.
Transplantation proceedings 1999;31(1-2):272-3.
1999: M Roy First
Immunologically high-risk recipient strategies.
Transplantation proceedings 1999;31(1-2):243-6.
1999: MB Shah; Jill E Martin; TJ Schroeder; M Roy First
Validity of open labeled versus blinded trials: a meta-analysis comparing Neoral and Sandimmune.
Transplantation proceedings 1999;31(1-2):217-9.
1998: G M Baker; Jill E Martin; Raymond Jang; TJ Schroeder; J A Armitstead; S Myre; M Roy First
Pharmacoeconomic analysis of mycophenolate mofetil versus azathioprine in primary cadaveric renal transplantation.
Transplantation proceedings 1998;30(8):4082-4.
1998: AJ Daoud; TJ Schroeder; M Shah; S Hariharan; V Ram Peddi; Pat Weiskittel; M Roy First
A comparison of the safety and efficacy of mycophenolate mofetil, prednisone and cyclosporine and mycophenolate mofetil, and prednisone and tacrolimus.
Transplantation proceedings 1998;30(8):4079-81.
1998: PR Fleck; TJ Schroeder; A J Dauod; V Ram Peddi; M Roy First
Tacrolimus use in kidney-pancreas recipients is associated with less acute renal dysfunction than cyclosporine.
Transplantation proceedings 1998;30(8):4070-2.
1998: MB Shah; Jill E Martin; TJ Schroeder; M Roy First
A meta-analysis to assess the safety and tolerability of two formulations of cyclosporine: Sandimmune and Neoral.
Transplantation proceedings 1998;30(8):4048-53.
1998: M Roy First; Pat Weiskittel; M Shah; V Ram Peddi; DM Canafax; TJ Schroeder
Conversion of stable renal transplant recipients from Sandimmune to Sang-35, a Neoral-equivalent cyclosporine formulation, using a dose-adjusted method.
Transplantation proceedings 1998;30(8):3955-7.
1998: M Roy First; Rita R Alloway; TJ Schroeder
Development of Sang-35: a cyclosporine formulation bioequivalent to Neoral.
Clinical transplantation 1998;12(6):518-24.
1998: V Ram Peddi; S Kamath; Rino Munda; AM Demmy; J Wesley Alexander; M Roy First
Use of tacrolimus eliminates acute rejection as a major complication following simultaneous kidney and pancreas transplantation.
Clinical transplantation 1998;12(5):401-5.
1998: M Roy First; V Ram Peddi
Malignancies complicating organ transplantation.
Transplantation proceedings 1998;30(6):2768-70.
1998: M Roy First; Pat Weiskittel; M Burton; M Shah; D Dreyer; PR Fleck; C Bey; R Peddi; DM Canafax; TJ Schroeder
Conversion of stable renal transplant recipients from Sandimmune to Sang-35, a novel cyclosporine formulation, using a dose-normalized equivalence method.
Transplantation proceedings 1998;30(5):1701-5.
1998: MB Shah; Jill E Martin; TJ Schroeder; M Roy First
Evaluation of the safety and tolerability of Neoral and Sandimmune: a meta-analysis.
Transplantation proceedings 1998;30(5):1697-700.
1998: A J Kaplan; J F Valente; M Roy First; AM Demmy; Rino Munda
Early operative intervention for urologic complications of kidney-pancreas transplantation.
World journal of surgery 1998;22(8):890-4.
1998: A Osama Gaber; M Roy First; R J Tesi; Robert S Gaston; R Mendez; Laura L Mulloy; J A Light; Lillian W Gaber; E Squiers; R J Taylor; J F Neylan; Robert W Steiner; Stuart J Knechtle; Douglas J Norman; Fuad S Shihab; Giacomo P Basadonna; D C Brennan; Ernest Hodge; B D Kahan; L Kahan; S Steinberg; E Steve Woodle; L Chan; John M Ham; TJ Schroeder
Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation.
Transplantation 1998;66(1):29-37.
1998: V Ram Peddi; J Whiting; Pat Weiskittel; J Wesley Alexander; M Roy First
Characteristics of long-term renal transplant survivors.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1998;32(1):101-6.
1998: V Ram Peddi; Rino Munda; AM Demmy; J Wesley Alexander; M Roy First
Long-term kidney and pancreas function with tacrolimus immunosuppression following simultaneous kidney and pancreas transplantation.
Transplantation proceedings 1998;30(4):1541-3.
1998: S Kamath; D Dean; V Ram Peddi; TJ Schroeder; J Wesley Alexander; T Cavallo; M Roy First
Primary therapy with OKT3 for biopsy-proven acute renal allograft rejection.
Transplantation proceedings 1998;30(4):1178-80.
1998: R D Guttmann; Jean-Paul Soulillou; Linda Moore; M Roy First; A Osama Gaber; P Pouletty; TJ Schroeder
Proposed consensus for definitions and endpoints for clinical trials of acute kidney transplant rejection.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1998;31(6 Suppl 1):S40-6.
1998: I A Al-Awwa; S Hariharan; M Roy First
Importance of allograft biopsy in renal transplant recipients: correlation between clinical and histological diagnosis.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1998;31(6 Suppl 1):S15-8.
1998: V Ram Peddi; AM Demmy; Rino Munda; J Wesley Alexander; M Roy First
Tacrolimus eliminates acute rejection as a major complication following simultaneous kidney and pancreas transplantation.
Transplantation proceedings 1998;30(2):509-11.
1998: V Ram Peddi; S Kamath; TJ Schroeder; Rino Munda; M Roy First
Efficacy of OKT3 as primary therapy for histologically confirmed acute renal allograft rejection in simultaneous kidney and pancreas transplant recipients.
Transplantation proceedings 1998;30(2):285-7.
1998: Lillian W Gaber; Linda Moore; A Osama Gaber; M Roy First; R D Guttmann; P Pouletty; TJ Schroeder; Jean-Paul Soulillou
Utility of standardized histological classification in the management of acute rejection. 1995 Efficacy Endpoints Conference.
Transplantation 1998;65(3):376-80.
1998: M Roy First
Clinical application of immunosuppressive agents in renal transplantation.
The Surgical clinics of North America 1998;78(1):61-76.
1998: James F Whiting; MS Golconda; Roger Smith; S O'Brien; M Roy First; J Wesley Alexander
Economic costs of expanded criteria donors in renal transplantation.
Transplantation 1998;65(2):204-7.
1997: MS Golconda; James F Whiting; Roger Smith; R Hayes; J Wesley Alexander; M Roy First
Long-term outcome of kidney transplantation from expanded criteria donors: a single center experience.
Transplantation proceedings 1997;29(8):3379-81.
1997: M Roy First
The donor supply.
Transplantation proceedings 1997;29(8):3299-3300.
1997: James F Whiting; MS Golconda; Roger Smith; S O'Brien; M Roy First; J Wesley Alexander
Clinical and economic outcomes of expanded criteria donors in renal transplantation.
Transplantation proceedings 1997;29(8):3258.
1997: S Kamath; D Dean; V Ram Peddi; TJ Schroeder; J Wesley Alexander; T Cavallo; M Roy First
Efficacy of OKT3 as primary therapy for histologically confirmed acute renal allograft rejection.
Transplantation 1997;64(10):1428-32.
1997: AJ Daoud; TJ Schroeder; JM Kano; HR Horn; HB Moran; M Roy First
The US compassionate experience with thymoglobulin for the treatment of resistant acute rejection.
Transplantation proceedings 1997;29(7A):18S-20S.
1997: F Rahusen; Rino Munda; S Hariharan; M Roy First; AM Demmy
Combined kidney-pancreas and parathyroid transplantation: a case report.
Clinical transplantation 1997;11(4):341-3.
1997: John F Valente; S Hariharan; V Ram Peddi; TJ Schroeder; Cora K Ogle; J Wesley Alexander; M Roy First
Causes of renal allograft loss in black vs. white transplant recipients in the cyclosporine era.
Clinical transplantation 1997;11(3):231-6.
1997: M Roy First
Xenotransplantation: social, ethical, religious, and political issues.
Kidney international. Supplement 1997;58():S46-7.
1997: S Hariharan; V Ram Peddi; Rino Munda; AM Demmy; TJ Schroeder; J Wesley Alexander; M Roy First
Long-term renal and pancreas function with tacrolimus rescue therapy following kidney/pancreas transplantation.
Transplantation proceedings 1997;29(1-2):652-3.
1997: M el-Ghoroury; S Hariharan; V Ram Peddi; Rino Munda; TJ Schroeder; AM Demmy; J Wesley Alexander; M Roy First
Efficacy and safety of tacrolimus versus cyclosporine in kidney and pancreas transplant recipients.
Transplantation proceedings 1997;29(1-2):649-51.
1997: TJ Schroeder; R Levy; P Pouletty; M Roy First
A generic cyclosporine development program.
Transplantation proceedings 1997;29(1-2):1235-8.
1997: M Roy First
Cadaveric organ procurement--an overview of two aspects: donor hospital networks, and minority donation.
Transplantation proceedings 1997;29(1-2):70-2.
1997: M Roy First
Controversies in organ donation: minority donation and living unrelated renal donors.
Transplantation proceedings 1997;29(1-2):67-9.
1997: Lillian W Gaber; Linda Moore; A Osama Gaber; M Roy First; R D Guttmann; P Pouletty; TJ Schroeder; Jean-Paul Soulillou
A multicenter report on the utilization of Banff grading in acute renal rejection. The 1995 Efficacy Endpoints Conference.
Transplantation proceedings 1997;29(1-2):184-5.
1997: V Ram Peddi; D E Dean; S Hariharan; T Cavallo; TJ Schroeder; M Roy First
Proteinuria following renal transplantation: correlation with histopathology and outcome.
Transplantation proceedings 1997;29(1-2):101-3.
1997: M Roy First
An update on new immunosuppressive drugs undergoing preclinical and clinical trials: potential applications in organ transplantation.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1997;29(2):303-17.
1997: V Ram Peddi; S Hariharan; TJ Schroeder; M Roy First
Impact of ganciclovir prophylaxis on cytomegalovirus infection in recipients of cadaveric renal allografts.
Nephron 1997;76(1):49-55.
1996: W F Marterre; S Hariharan; M Roy First; J Wesley Alexander
Gastric bypass in morbidly obese kidney transplant recipients.
Clinical transplantation 1996;10(5):414-9.
1996: S Hariharan; R D Smith; R Viero; M Roy First
Diabetic nephropathy after renal transplantation. Clinical and pathologic features.
Transplantation 1996;62(5):632-5.
1996: T Cavallo; M Roy First
"Recurrence" of cyclosporine nephropathy in a heart transplant recipient.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1996;28(3):466-8.
1996: D G Skannal; Menachem Miodovnik; L J Dungy-Poythress; M Roy First
Successful pregnancy after combined renal-pancreas transplantation: a case report and literature review.
American journal of perinatology 1996;13(6):383-7.
1996: TJ Schroeder; M Shah; S Hariharan; M Roy First
Increased resources are required in patients with low cyclosporine bioavailability.
Transplantation proceedings 1996;28(4):2151-5.
1996: S Hariharan; Rino Munda; T Cavallo; AM Demmy; TJ Schroeder; J Wesley Alexander; M Roy First
Rescue therapy with tacrolimus after combined kidney/pancreas and isolated pancreas transplantation in patients with severe cyclosporine nephrotoxicity.
Transplantation 1996;61(8):1161-5.
1996: S Hariharan; J Wesley Alexander; TJ Schroeder; M Roy First
Outcome of cadaveric renal transplantation by induction treatment in the cyclosporine era.
Clinical transplantation 1996;10(2):186-90.
1996: V Ram Peddi; S Hariharan; M Roy First
Disseminated histoplasmosis in renal allograft recipients.
Clinical transplantation 1996;10(2):160-5.
1996: M Roy First; TJ Schroeder; A P Monaco; M A Simpson; J J Curtis; V T Armenti
Cyclosporine bioavailability: dosing implications and impact on clinical outcomes in select transplantation subpopulations.
Clinical transplantation 1996;10(1 Pt 1):55-9.
1996: S Rossi; T Schroeder; K Muth; D Hanto; Rino Munda; S Hariharan; M Roy First; Frederick C Ryckman; William F Balistreri
Serial monitoring of soluble interleukin-2 receptor as a rapid marker of cytomegalovirus infection and response to antiviral therapy.
Clinical transplantation 1996;10(1 Pt 1):45-50.
1996: V Ram Peddi; S Hariharan; TJ Schroeder; M Roy First
Role of granulocyte colony stimulating factor (G-CSF) in reversing neutropenia in renal allograft recipients.
Clinical transplantation 1996;10(1 Pt 1):20-3.
1996: R M Viero; M Roy First; T Cavallo
Detection of Epstein-Barr virus message in renal allografts.
Transplantation 1996;61(2):321-3.
1995: M el-Ghoroury; S Hariharan; Rino Munda; AM Demmy; TJ Schroeder; J Wesley Alexander; M Roy First
Comparison between methylprednisolone and OKT3 treatment for the first acute rejection episode in combined kidney and pancreas transplant recipients.
Transplantation proceedings 1995;27(6):3133-4.
1995: V Ram Peddi; S Hariharan; Rino Munda; TJ Schroeder; M Roy First
Impact of ganciclovir prophylaxis on cytomegalovirus infection in cadaveric kidney vs combined kidney and pancreas transplantation.
Transplantation proceedings 1995;27(6):3076-7.
1995: S Hariharan; Rino Munda; AM Demmy; TJ Schroeder; J Wesley Alexander; M Roy First
Conversion from cyclosporine to tacrolimus after pancreas transplantation.
Transplantation proceedings 1995;27(6):2981-2.
1995: D G Skannal; L J Dungy-Poythress; Menachem Miodovnik; M Roy First
Pregnancy in a combined liver and kidney transplant recipient with type 1 primary hyperoxaluria.
Obstetrics and gynecology 1995;86(4 Pt 2):641-3.
1995: M Roy First; C A Combs; Pat Weiskittel; M Miodovnik
Lack of effect of pregnancy on renal allograft survival or function.
Transplantation 1995;59(4):472-6.
1995: TJ Schroeder; S Hariharan; M Roy First
Variations in bioavailability of cyclosporine and relationship to clinical outcome in renal transplant subpopulations.
Transplantation proceedings 1995;27(1):837-9.
1994: TJ Schroeder; S Hariharan; M Roy First
Relationship between cyclosporine bioavailability and clinical outcome in renal transplant recipients.
Transplantation proceedings 1994;26(5):2787-90.
1994: R L Madden; TJ Schroeder; J Wesley Alexander; M Roy First
Single dose OKT3: adverse effects, pharmacokinetics, and anti-OKT3 antibody response.
Transplantation science 1994;4(1):111-4.
1994: TJ Schroeder; A T Michael; M Roy First; S Hariharan; G Bhat; Douglas W Hanto; Frederick C Ryckman; William F Balistreri
Variations in serum OKT3 concentration based upon age, sex, transplanted organ, treatment regimen, and anti-OKT3 antibody status.
Therapeutic drug monitoring 1994;16(4):361-7.
1994: M Roy First; J F Neylan; L L Rocher; A Tejani
Hypertension after renal transplantation.
Journal of the American Society of Nephrology : JASN 1994;4(8 Suppl):S30-6.
1994: TJ Schroeder; M Roy First
Monoclonal antibodies in organ transplantation.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1994;23(1):138-47.
1993: S Hariharan; TJ Schroeder; Pat Weiskittel; J W Alexander; M Roy First
Prednisone withdrawal in HLA identical and one haplotype-matched live-related donor and cadaver renal transplant recipients.
Kidney international. Supplement 1993;43():S30-5.
1993: M Roy First
Long-term complications after transplantation.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1993;22(3):477-86.
1993: S J Rossi; TJ Schroeder; S Hariharan; M Roy First
Prevention and management of the adverse effects associated with immunosuppressive therapy.
Drug safety : an international journal of medical toxicology and drug experience 1993;9(2):104-31.
1993: S Hariharan; TJ Schroeder; M Roy First
Effect of race on renal transplant outcome.
Clinical transplantation 1993;7(3):235-9.
1993: TJ Schroeder; N Sridhar; Amadeo J Pesce; J Wesley Alexander; M Roy First
Clinical correlations of cyclosporine-specific and -nonspecific assays in stable renal transplants, acute rejection, and cyclosporine nephrotoxicity.
Therapeutic drug monitoring 1993;15(3):190-4.
1993: M Roy First; TJ Schroeder; A Michael; S Hariharan; Pat Weiskittel; J Wesley Alexander
Cyclosporine-ketoconazole interaction. Long-term follow-up and preliminary results of a randomized trial.
Transplantation 1993;55(5):1000-4.
1993: TJ Schroeder; S Hariharan; M Roy First
Antibody response to OKT3 and methods for monitoring.
Transplantation proceedings 1993;25(2 Suppl 1):77-80.
1993: M Roy First; TJ Schroeder; S Hariharan; Pat Weiskittel
Reduction of the initial febrile response to OKT3 with indomethacin.
Transplantation proceedings 1993;25(2 Suppl 1):52-4.
1993: M Roy First; TJ Schroeder; S Hariharan
OKT3-induced cytokine-release syndrome: renal effects (cytokine nephropathy).
Transplantation proceedings 1993;25(2 Suppl 1):25-6.
1993: R L Madden; Rino Munda; S Hariharan; J Wesley Alexander; M Roy First
Outcome of cadaver kidneys using nonideal donors.
Transplantation proceedings 1993;25(1 Pt 2):1568-9.
1993: M Roy First; TJ Schroeder; A Michael; S Hariharan; Pat Weiskittel; J Wesley Alexander
Safety and efficacy of long-term cyclosporine-ketoconazole administration and preliminary results of a randomized trial.
Transplantation proceedings 1993;25(1 Pt 1):591-4.
1993: J Wesley Alexander; C B Davies; M Roy First; B R Cofer; Rino Munda; R L Madden; S Hariharan; TJ Schroeder
Single pretransplant donor-specific transfusion in cadaver and living related donor renal transplantation.
Transplantation proceedings 1993;25(1 Pt 1):485-7.
1993: TJ Schroeder; M Roy First; C Pouletty; S Hariharan; P Pouletty
Rapid detection of anti-OKT3 antibodies with the Transtat assay.
Transplantation 1993;55(2):297-9.
1992: N R Sridhar; M Blanton; L Whitacre; K Balakrishnan; M Roy First
Flow cytometric evaluation of cytotoxic peripheral blood lymphocytes in acute renal graft rejection.
Journal of the American Society of Nephrology : JASN 1992;3(6):1220-6.
1992: C B Davies; J Wesley Alexander; B R Cofer; M Roy First; TJ Schroeder
Efficacy of a single pretransplant donor-specific transfusion and cyclosporin A administered 24 to 48 hours before one-haplotype-mismatched living related donor kidney transplant.
Annals of surgery 1992;215(6):618-25; discussion 626.
1992: J Wesley Alexander; George Babcock; M Roy First; C B Davies; R L Madden; Rino Munda; I Penn; J P Fidler; B R Cofer; G Stephens
The induction of immunologic hyporesponsiveness by preoperative donor-specific transfusions and cyclosporine in human cadaveric transplants. A preliminary trial.
Transplantation 1992;53(2):423-7.
1992: M Roy First; TJ Schroeder; S Hariharan; J Wesley Alexander; Pat Weiskittel
The effect of indomethacin on the febrile response following OKT3 therapy.
Transplantation 1992;53(1):91-4.
1992: TJ Schroeder; T Helling; RM McKenna; D Rush; J R Jeffrey; B Brewer; L A Martin; D Traylor; R A Fisher; M Roy First
A multicenter study to evaluate a novel assay for quantitation of soluble interleukin 2 receptor in renal transplant recipients.
Transplantation 1992;53(1):34-40.
1992: N R Sridhar; Rino Munda; K Balakrishnan; M Roy First
Evaluation of flowcytometric crossmatching in renal allograft recipients.
Nephron 1992;62(3):262-6.
1992: M Roy First
Transplantation in the nineties.
Transplantation 1992;53(1):1-11.
1991: N R Sridhar; J I Tchervenkov; M A Weiss; Y M Hijazi; M Roy First
Disseminated histoplasmosis in a renal transplant patient: a cause of renal failure several years following transplantation.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1991;17(6):719-21.
1991: M Roy First; TJ Schroeder
Solid-organ transplantation in the pediatric population.
Clinical transplantation 1991;5(2 part 2):132-6.
1991: M Roy First; TJ Schroeder; J Wesley Alexander; G W Stephens; Pat Weiskittel; S A Myre; Amadeo J Pesce
Cyclosporine dose reduction by ketoconazole administration in renal transplant recipients.
Transplantation 1991;51(2):365-70.
1991: R A Fisher; J I Tchervenkov; TJ Schroeder; J Wesley Alexander; Rino Munda; I Penn; M Carey; M Roy First
Efficacy of induction therapy in cadaveric renal transplantation comparing rabbit antithymocyte serum and Minnesota antilymphoblast globulin.
Transplantation proceedings 1991;23(1 Pt 2):1253-5.
1991: TJ Schroeder; M A Weiss; R D Smith; G W Stephens; M Roy First
The efficacy of OKT3 in vascular rejection.
Transplantation 1991;51(2):312-5.
1991: TJ Schroeder; M A Weiss; R D Smith; G W Stephens; M Carey; M Roy First
The use of OKT3 in the treatment of acute vascular rejection.
Transplantation proceedings 1991;23(1 Pt 2):1043-5.
1991: J Wesley Alexander; M Roy First; S Hariharan; I Penn; T Schroeder; Frederick C Ryckman; Rino Munda; G Bhat; R Bolce
Recent contributions to transplantation at the University of Cincinnati.
Clinical transplants 1991;():159-78.
1991: S A Myre; T J Schoeder; V R Grund; T L Wandstrat; P G Nicely; Amadeo J Pesce; M Roy First
Critical ketoconazole dosage range for ciclosporin clearance inhibition in the dog.
Pharmacology 1991;43(5):233-41.
1990: J I Tchervenkov; Rino Munda; M Weiss; M Roy First; J Wesley Alexander
Adult respiratory distress syndrome following chronic rejection of a pancreatic allograft--a case report.
Transplantation 1990;50(5):883-4.
1990: N Sridhar; TJ Schroeder; Amadeo J Pesce; M Roy First
Clinical correlations of cyclosporine HPLC and FPIA levels in renal transplant recipients.
Transplantation proceedings 1990;22(3):1257-9.
1990: Amadeo J Pesce; TJ Schroeder; M Roy First
An evaluation of cyclosporine monitoring by nonselective fluorescence polarization immunoassay.
Transplantation proceedings 1990;22(3):1171-4.
1990: TJ Schroeder; Rino Munda; S H Pedersen; P E Hurtubise; J Wesley Alexander; M Roy First
Failure of orthoclone OKT3 retreatment in a pancreas transplant recipient with antimurine antibodies.
Journal of clinical laboratory analysis 1990;4(2):99-101.
1990: TJ Schroeder; M Roy First; M E Mansour; P E Hurtubise; S Hariharan; Frederick C Ryckman; Rino Munda; David B Melvin; I Penn; W F Ballistreri
Antimurine antibody formation following OKT3 therapy.
Transplantation 1990;49(1):48-51.
1990: M Roy First
Annual review of transplantation.
Clinical transplants 1990;():357-73.
1989: M Roy First; TJ Schroeder; M A Carey; D S Chavinson
Effect of race on transplant outcome and response to OKT3 monoclonal antibody therapy.
Transplantation proceedings 1989;21(6):3949-52.
1989: M Roy First; TJ Schroeder; Pat Weiskittel; S A Myre; J Wesley Alexander; Amadeo J Pesce
Concomitant administration of cyclosporin and ketoconazole in renal transplant recipients.
Lancet 1989;2(8673):1198-201.
1989: TJ Schroeder; M Roy First; M E Mansour; J Wesley Alexander; I Penn
Prophylactic use of OKT3 in immunologic high-risk cadaver renal transplant recipients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1989;14(5 Suppl 2):14-8.
1989: TJ Schroeder; M Roy First; P E Hurtubise; D J Marmer; D M Martin; M E Mansour; David B Melvin
Immunologic monitoring with Orthoclone OKT3 therapy.
The Journal of heart transplantation 1989;8(5):371-80.
1989: K Balakrishnan; Rino Munda; M Roy First; J Wesley Alexander
Outcome of donor specific transfusion renal transplants across B cell positive crossmatches.
Transplantation proceedings 1989;21(1 Pt 2):1836.
1989: Rino Munda; M Hutchins; M Roy First; M Carey; T Schroeder; J Wesley Alexander
Infection in OKT3-treated patients receiving additional antirejection therapy.
Transplantation proceedings 1989;21(1 Pt 2):1763-5.
1989: M Roy First; TJ Schroeder; P E Hurtubise; M E Mansour; I Penn; Rino Munda; William F Balistreri; J Wesley Alexander; David B Melvin; J P Fidler
Immune monitoring during retreatment with OKT3.
Transplantation proceedings 1989;21(1 Pt 2):1753-4.
1989: S Hariharan; M Roy First; Rino Munda; I Penn; TJ Schroeder; J Fidler; Pat Weiskittel; J Wesley Alexander
Prednisone withdrawal in HLA-identical living related donor transplant recipients.
Transplantation proceedings 1989;21(1 Pt 2):1617-9.
1989: M Roy First; R D Smith; M A Weiss; TJ Schroeder; K S Kant; Rino Munda; G W Stephens; I Penn; J Wesley Alexander
Cyclosporine-associated glomerular and arteriolar thrombosis following renal transplantation.
Transplantation proceedings 1989;21(1 Pt 2):1567-70.
1989: Rino Munda; M Roy First; G Kranias; J Wesley Alexander
Effects of pancreatic transplantation on diabetic complications.
Transplantation proceedings 1989;21(1 Pt 3):2865-6.
1989: S A Myre; TJ Schroeder; David B Melvin; Amadeo J Pesce; J A Collins; G W Stephens; M Roy First
Comparison of the safety and efficacy of oral vs constant-rate intravenous infusion cyclosporine immediately following orthotopic heart transplantation.
Transplantation proceedings 1989;21(1 Pt 3):2484-6.
1989: TJ Schroeder; M E Brunson; Amadeo J Pesce; L L Hindenlang; P A Mauser; D I Ruckrigl; M L Weibel; G Wadih; M Roy First
A comparison of the clinical utility of the radioimmunoassay, high-performance liquid chromatography, and TDx cyclosporine assays in outpatient renal transplant recipients.
Transplantation 1989;47(2):262-6.
1989: TJ Schroeder; Amadeo J Pesce; L L Hindenlang; P A Mauser; D L Ruckrigl; M L Weibel; G Wadih; M Roy First
An evaluation of the cyclosporine and metabolites whole blood TDx assay.
Therapeutic drug monitoring 1989;11(4):480-2.
1989: TJ Schroeder; S A Myre; David B Melvin; J Van der Bel-Kahn; G W Stephens; J A Collins; Randall K Wolf; L L Brown; Amadeo J Pesce; M Roy First
Efficacy and safety of constant-rate intravenous cyclosporine infusion immediately after heart transplantation.
The Journal of heart transplantation 1989;8(1):5-10.
1989: M Roy First; TJ Schroeder; P E Hurtubise; M E Mansour; I Penn; Rino Munda; William F Balistreri; J Wesley Alexander; David B Melvin; J P Fidler
Successful retreatment of allograft rejection with OKT3.
Transplantation 1989;47(1):88-91.
1988: B Shah; M Roy First; Rino Munda; I Penn; J P Fidler; J Wesley Alexander
Current experience with renal transplantation in older patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1988;12(6):516-23.
1988: C W Clardy; TJ Schroeder; S A Myre; N K Wadhwa; Amadeo J Pesce; M Roy First; P T McEnery; William F Balistreri; R E Harris; David B Melvin
Clinical variability of cyclosporine pharmacokinetics in adult and pediatric patients after renal, cardiac, hepatic, and bone-marrow transplants.
Clinical chemistry 1988;34(10):2012-5.
1988: Rino Munda; TJ Schroeder; S A Pedersen; C W Clardy; N K Wadhwa; S A Myre; G W Stephens; Amadeo J Pesce; J Wesley Alexander; M Roy First
Cyclosporine pharmacokinetics in pancreas transplant recipients.
Transplantation proceedings 1988;20(2 Suppl 2):487-90.
1988: TJ Schroeder; Amadeo J Pesce; F M Hassan; J R Wermeling; A Warner; K T Schlueter; M Roy First
Comparison of Abbott TDx fluorescence polarization immunoassay, Sandoz radioimmunoassay, and high-performance liquid chromatography methods for the assay of serum cyclosporine.
Transplantation proceedings 1988;20(2 Suppl 2):345-7.
1988: B Shah; M Roy First; N C Mendoza; D H Clyne; J W Alexander; M A Weiss
Alport's syndrome: risk of glomerulonephritis induced by anti-glomerular-basement-membrane antibody after renal transplantation.
Nephron 1988;50(1):34-8.
1987: N K Wadhwa; TJ Schroeder; Amadeo J Pesce; S A Myre; C W Clardy; M Roy First
Cyclosporine drug interactions: a review.
Therapeutic drug monitoring 1987;9(4):399-406.
1987: TJ Schroeder; David B Melvin; C W Clardy; N K Wadhwa; S A Myre; J M Reising; Randall K Wolf; J A Collins; Amadeo J Pesce; M Roy First
Use of cyclosporine and ketoconazole without nephrotoxicity in two heart transplant recipients.
The Journal of heart transplantation 1987;6(2):84-9.
1987: N K Wadhwa; TJ Schroeder; E O'Flaherty; Amadeo J Pesce; S A Myre; M Roy First
The effect of oral metoclopramide on the absorption of cyclosporine.
Transplantation proceedings 1987;19(1 Pt 2):1730-3.
1987: N K Wadhwa; TJ Schroeder; E O'Flaherty; Amadeo J Pesce; S A Myre; M Roy First
The effect of oral metoclopramide on the absorption of cyclosporine.
Transplantation 1987;43(2):211-3.
1987: Rino Munda; M A Weiss; M Roy First; J Wesley Alexander
Synchronous pancreatic and renal allografts with urinary tract drainage of the pancreas.
Transplantation proceedings 1987;19(1 Pt 3):2343-4.
1987: N K Wadhwa; TJ Schroeder; E O'Flaherty; Amadeo J Pesce; S A Myre; Rino Munda; M Roy First
Interaction between erythromycin and cyclosporine in a kidney and pancreas allograft recipient.
Therapeutic drug monitoring 1987;9(1):123-5.
1986: M Roy First; J Wesley Alexander; N Wadhwa; I Penn; Rino Munda; J P Fidler; Pat Weiskittel
The use of low doses of cyclosporine, azathioprine, and prednisone in renal transplantation.
Transplantation proceedings 1986;18(2 Suppl 1):132-5.